Health authorities warn against Melanotan II amid hospitalization reports
Multiple European agencies have re-issued warnings following a cluster of serious adverse events.
by Editorial team
The warnings
Health agencies in the UK, Netherlands, and Australia have re-issued public warnings about Melanotan II this month.
The warnings follow a small cluster of hospitalizations involving nausea, hypertension, and one case of priapism.
What is being sold
Melanotan II is widely marketed online as a tanning peptide but is not approved for human use in any jurisdiction.
Many products tested by regulators contained impurities, incorrect dosages, or completely different compounds.
Advice
Authorities recommend against use and urge anyone experiencing side effects to seek medical attention immediately.
Do not assume injectable tanning peptides sold online are what the label claims.